华康生物医学
港股通 官网
( 08622.hk)
市盈率-11.94市净率1.32市销率2.91股息率0.00%上市时间2018-12-13股价0.16港币 (-6.98% , 22.49万港币) 市值8,007.55万港币总股本5.00亿上市至今年化投资收益率-16.59%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (0): 双击编辑备注
发表讨论

华康生物医学(08622) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1周靖文Independent Non Executive Director2023-08-02--
2周國輝Independent Non Executive Director2020-12-16--
3鄭發丁Independent Non Executive Director - A/F2020-09-01--
4何嘉明Executive Director2020-01-14--
5陳健生Independent Non Executive Director2018-11-26--
6楊煒秋Independent Non Executive Director2018-11-262020-12-16
7郭志成Independent Non Executive Director - A/F2018-11-262020-09-01
8潘禮賢Executive Director2017-08-03--
9張春光Executive DirectorCEO2017-08-03--
10張曙光Executive DirectorChairman2017-08-03--